Literature DB >> 6445766

Evidence for both histamine H1- and H2-receptors in the gastric vasculature of the cat.

C A Harvey, D A Owen, K D Shaw.   

Abstract

1 Experiments have been done to study the gastric vascular response to histamine given intra-arterially in the cat.2 In experiments utilising pump perfusion of the stomach at constant flow rates, rapid intra-arterial injections of histamine elicited dose-dependent vasodilatation. The dose-response curve to histamine was displaced to the right by mepyramine and further to the right by mepyramine plus cimetidine. Cimetidine alone did not displace the histamine dose-response curve. This interaction between histamine and histamine antagonists is very similar to the interaction observed in other vascular beds.3 Intra-arterial infusions of histamine also caused vasodilatation with increased gastric blood flow, measured with an electromagnetic flow probe. Mepyramine reduced the immediate increase in blood flow during each infusion, although responses in the later stages of the infusions were unaltered. Cimetidine had no effect on the immediate response but reduced sustained responses to histamine. Treatment with mepyramine and cimetidine was required to abolish histamine responses.4 Infusions of 2-(2-aminoethyl) pyridine and dimaprit also increased gastric blood flow.5 These results indicate the involvement of both H(1)- and H(2)-receptors in histamine-induced gastric vasodilatation. There appears to be a time-base in the interaction between histamine and vascular histamine receptors; H(1)-receptor responses preceding H(2)-receptor responses.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6445766      PMCID: PMC2044175          DOI: 10.1111/j.1476-5381.1980.tb10878.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  11 in total

1.  Comparison of gastric mucosal blood flow as determined by aminopyrine clearance and gamma-labeled microspheres.

Authors:  L H Archibald; F G Moody; M A Simons
Journal:  Gastroenterology       Date:  1975-09       Impact factor: 22.682

2.  Dimaprit -(S-[3-(N,N-dimethylamino)prophyl]isothiourea) - a highly specific histamine H2 -receptor agonist. Part 1. Pharmacology.

Authors:  M E Parsons; D A Owen; C R Ganellin; G J Durant
Journal:  Agents Actions       Date:  1977-03

3.  Chemical differentiation of histamine H1- and H2-receptor agonists.

Authors:  G J Durant; C R Ganellin; M E Parsons
Journal:  J Med Chem       Date:  1975-09       Impact factor: 7.446

4.  Comparison of gastrin and histamine on gastric mucosal blood flow.

Authors:  E D Jacobson; A C Chang
Journal:  Proc Soc Exp Biol Med       Date:  1969-02

Review 5.  The gastrointestinal circulation.

Authors:  G Lanciault; E D Jacobson
Journal:  Gastroenterology       Date:  1976-11       Impact factor: 22.682

6.  Impromidine (SK&F 92676) is a very potent and specific agonist for histamine H2 receptors.

Authors:  G J Durant; W A Duncan; C R Ganellin; M E Parsons; R C Blakemore; A C Rasmussen
Journal:  Nature       Date:  1978-11-23       Impact factor: 49.962

7.  Effect of metiamide, a histamine H2-receptor antagonist, on mucosal blood flow and serum gastrin level.

Authors:  S J Konturek; J Tasler; W Obtulowicz; J F Rehfeld
Journal:  Gastroenterology       Date:  1974-05       Impact factor: 22.682

8.  Histamine H1- and H2-receptor vasodilation of canine intestinal circulation.

Authors:  W Pawlik; L L Tague; B L Tepperman; T A Miller; E D Jacobson
Journal:  Am J Physiol       Date:  1977-09

9.  Histamine receptors in peripheral vascular beds in the cat.

Authors:  S B Flynn; D A Owen
Journal:  Br J Pharmacol       Date:  1975-10       Impact factor: 8.739

10.  A study of the vascular and acid-secretory responses of the rat gastric mucosa to histamine.

Authors:  I H Main; B J Whittle
Journal:  J Physiol       Date:  1976-05       Impact factor: 5.182

View more
  10 in total

1.  H1 and H2 receptor antagonists and hepatic oxygen supply-demand relationship in pigs.

Authors:  L Roytblat; S Gelman; T Henderson; D Parks
Journal:  Can J Anaesth       Date:  1991-01       Impact factor: 5.063

2.  Cardiovascular studies with SK&F 93319, an antagonist of histamine at both H1- and H2-receptors.

Authors:  C A Harvey; D A Owen
Journal:  Br J Pharmacol       Date:  1984-10       Impact factor: 8.739

3.  In vivo characterization of histamine H1- and H2-receptors in the rat stomach microcirculation.

Authors:  A Koo
Journal:  Br J Pharmacol       Date:  1983-01       Impact factor: 8.739

Review 4.  Ranitidine versus cimetidine. A comparison of their potential to cause clinically important drug interactions.

Authors:  S R Smith; M J Kendall
Journal:  Clin Pharmacokinet       Date:  1988-07       Impact factor: 6.447

5.  Histamine-induced microvascular permeability increases in hamster skin: a response predominantly mediated by H2-receptors.

Authors:  D F Woodward; S E Ledgard
Journal:  Agents Actions       Date:  1986-08

6.  Different mechanisms of action of histamine in isolated arteries of the dog.

Authors:  M Konishi; N Toda; M Yamamoto
Journal:  Br J Pharmacol       Date:  1981-09       Impact factor: 8.739

7.  Comparative effects of cimetidine on biliary lipid secretion in fasted and fed rats.

Authors:  P Bonazzi; U Fredarra; G Novelli; A M Jezequel; F Orlandi
Journal:  Br J Exp Pathol       Date:  1984-10

8.  Effect of cimetidine on the hepatic extraction of indocyanine green, the portal pressure and the systemic circulation in patients with cirrhosis of the liver.

Authors:  R Herz; M Rössle; T Bonzel; E Keller; W Gerok
Journal:  Klin Wochenschr       Date:  1984-08-16

9.  Cimetidine and portal pressure in chronic liver disease.

Authors:  M J Cole; T F Shapero; E A Saibil
Journal:  Can Med Assoc J       Date:  1983-01-15       Impact factor: 8.262

10.  The effect of ranitidine on the plasma clearance and hepatic extraction of indocyanine green in patients with chronic liver disease.

Authors:  A A Dunk; W J Jenkins; A K Burroughs; R P Walt; T O Osuafor; S Sherlock; S Mackie; R Dick
Journal:  Br J Clin Pharmacol       Date:  1983-08       Impact factor: 4.335

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.